Top Markets
#1 Purr Purr +56.44%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 Pons Pons +49.99%
#4 Non-Playable Coin Non-Playable Coin +31.31%
#5 Kinetiq Kinetiq +26.80%
#6 StonkBroker StonkBroker +26.42%
#7 ApeX ApeX +24.48%
#8 Morpho Morpho +22.27%
#9 TENDIES TENDIES +21.98%
#10 OriginTrail OriginTrail +21.44%
Coin of the day
Purr Purr
설정
언어
한국어
통화
USD
테마
Kinnate Biopharma Inc. Kinnate Biopharma Inc.

Kinnate Biopharma Inc.

KNTE
주식 순위 #21072
Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily... Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily focused on identifying and advancing small-molecule drugs that target kinase enzymes to treat cancers defined by specific genetic markers. The company's product pipeline includes: KIN-2787: An inhibitor of rapidly accelerated fibrosarcoma (RAF), currently being developed to treat patients with lung cancer, melanoma, and other forms of solid tumors. KIN-3248: A small-molecule kinase inhibitor designed to counteract cancer-associated genetic mutations in the fibroblast growth factor receptors, specifically FGFR2 and FGFR3. KIN004 Program: This program encompasses early-stage small-molecule research, including a Cyclin-Dependent Kinase 12 (CDK12) inhibitor. Established in 2018, Kinnate Biopharma Inc. maintains its headquarters in San Francisco, California. It was formerly a division of Fount Therapeutics, LLC.
주가
$2.65
마지막 동기화: 2024-04-03
시가총액
$115.71M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Kinnate Biopharma Inc. (KNTE)

카테고리

Healthcare
Kinnate Biopharma Inc. (KNTE)의 주가 이력
최고 종가: $2.65 (2024-04-01 기준)

최저 종가: $40.13 (2020-12-01 기준)
Kinnate Biopharma Inc.의 주가 이력 (2020 ~ 2026)
연간 주가 성과
연도 성과
2024 15.54%
2023 -63.61%
2022 -64.96%
2021 -55.12%
2020 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH